Thyrocare Technologies Ltd (THYROCARE) — Insider Trading | 9 September 2026

9 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

API Holdings released pledge on 7,94,69,696 Thyrocare shares held by Docon

🔄 What Changed

Pledge on 7,94,69,696 shares fully released; no outstanding encumbrances remain

💡 Investor Takeaway

Share pledge release removes encumbrance but does not alter Docon's 51% ownership stake in Thyrocare

API Holdings released the pledge on 7,94,69,696 Thyrocare shares held by former promoter Docon, fully freeing them after repayment of INR 10,500 million in NCDs. Docon continues to hold 18,12,00,000 shares (51.02% of Thyrocare) with no encumbrances post-release. The scheme of amalgamation between Docon and API became effective on September 3, 2026, making API the successor entity. This disclosure complies with SEBI SAST Regulations 31(1) and 31(2) requirements for encumbrance release.

📄 View Original Announcement (PDF)

📊 Stock Analysis — THYROCARE ✨ Ask AI About This

About Thyrocare Technologies Ltd (THYROCARE)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹8,700.77 CrP/E: 49.5ROE: 34.4%ROCE: 45.6%Div Yield: 1.28%

View full THYROCARE stock details →

📡 Get AI alerts when THYROCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THYROCARE — Free

💡 Ask AI about this filing

"What is Docon's current shareholding percentage in Thyrocare?""How does the NCD repayment impact API's financial position?""When did the scheme of amalgamation become effective?"

Ask AI Free →

📊 More THYROCARE filings

🟡 Voting Results — 28 September 2026Thyrocare Technologies proposed two special resolutions via postal ballot: approval to purchase land...
Announcement — 24 September 2026Thyrocare Technologies has closed its insider trading window effective October 1, 2026, until 48 hou...
🟡 Board Meeting — 24 September 2026Thyrocare Technologies approved the grant of 1,92,000 employee stock options at a Rs. 10 exercise pr...
🟡 Board Meeting — 21 September 2026Thyrocare Technologies announced the board approved the sale of its entire 100% stake in radiology s...
🔴 Corporate Action — 21 September 2026Thyrocare Technologies announced on September 21, 2026, that its board approved the sale of its enti...

See all THYROCARE filings →

🔥 Also filed on 9 September 2026

INDUSINDBKIndusInd Bank LtdCorporate Action 543745SVS Ventures LtdAnnual Report FSLFirstsource Solutions LtdCorporate Action 544343CapitalNumbers Infotech LtdCorporate Action LODHALodha Developers LtdCorporate Action HORIZONINDHorizon Industrial Parks LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THYROCARE files new disclosures

Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.